Analyst Insights

Maxim Keeps ‘Buy’ On Vertex Pharmaceuticals, Raises Price Target To $107

In a research note issued today, Maxim Group analyst Jason Kolbert reiterated coverage with a “Buy” rating on Vertex Pharmaceuticals (VRTX) and increased his price target to $107.00 (from $92.

Roth Capital Maintains Buy On Micron Technology Following 3Q14 Results

In a research report published today, Roth Capital analyst Krishna Shankar maintained a Buy rating on Micron Technology, Inc. (MU) and a price target of $37.

Roth Capital Reiterates Buy On Ligand Pharmaceutical Following Partnership With TG

In a research note released today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Ligand Pharmaceutical (LGND) and a price target of $92.00 following …

Roth Capital Reiterates Buy On Hydrogenics Following Joint Venture With Kolon Water And Energy

In a research report released this morning, Roth Capital analyst Philip Shen reiterated coverage with a “Buy” rating on Hydrogenics Corporation (HYGS), and a price target of $30.00 following yesterday’s news …

eBay: “The Road Ahead Will Become Increasingly Challenging”, Says Topeka

Topeka Capital analyst Victor Anthony maintained a Hold rating on eBay Inc. (EBAY) stock today and reduced his price target from $60 to $54 following a …

Idexx Upgraded To Buy At Canaccord Following Release of Catalyst One

Canaccord Genuity analyst Mark Massaro yesterday upgraded shares of Idexx Laboratories (IDXX) from Hold to Buy and raised his target price to $148 (from $116) following the release of …

Canaccord Reiterates Buy Rating On 3D Systems; Sees 31% Upside

In a report published today, Canaccord analyst Robert Burleson reiterated a Buy rating and $75.00 price target on 3D Systems Corp.

Canaccord Maintains Speculative Buy On Rubicon Minerals Following The Infill Program Update

Today, Rubicon Minerals Corporation (RBY) updated the market on its infill program at the F2 Zone of its Phoenix Gold project in the Red …

Canaccord Downgrades Augusta Resource To Hold, Maintains C$3.50 PT

Hudbay Minerals (HBM) and Augusta Resources Corp. (AZC) today entered into a definitive agreement for the acquisition of AZC by HBM.

Canaccord Reiterates Buy On Hydrogenics Corporation, Keeps $32 PT

In a research report released today, Canaccord analyst Sara Elford reiterated coverage with a “Buy” rating on Hydrogenics Corporation (HYGS), and a price target of $32.00 representing a potential …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts